CollPlant Biotechnologies (CLGN) Other Non-Current Assets (2017 - 2023)

CollPlant Biotechnologies has reported Other Non-Current Assets for 7 years, with the latest figure at $26.7 million in Q4 2023.

• For the quarter ending Q4 2023, Other Non-Current Assets fell 10.68% year-over-year to $26.7 million; the trailing twelve-month figure through Dec 2023 stood at $26.7 million (down 10.68% YoY), and the FY2023 full-year result was $26.7 million, up 14088.3% from the prior year.
• Other Non-Current Assets for Q4 2023 stood at $26.7 million, down from $29.9 million in the prior quarter.
• The five-year high for Other Non-Current Assets was $41.3 million in Q1 2022, with the low at $3.5 million in Q4 2020.
• Historically, Other Non-Current Assets has averaged $18.4 million across 5 years, with a median of $17.7 million in 2021.
• Annual changes were most pronounced in 2019 — Other Non-Current Assets slipped 29.88% — and 2021, when it jumped 279.3%.
• CollPlant Biotechnologies' Other Non-Current Assets stood at $4.0 million in 2019, then retreated by 11.21% to $3.5 million in 2020, then jumped by 279.3% to $13.4 million in 2021, then jumped by 123.3% to $29.9 million in 2022, then dropped by 10.68% to $26.7 million in 2023.
• The last three Other Non-Current Assets figures came in at $26.7 million (Q4 2023), $29.9 million (Q4 2022), and $36.5 million (Q2 2022), per Business Quant data.